Clinical Trial Update: Tezepelumab Treatment in Korean Severe Asthma Patients

View source ↗

Summary

A clinical trial evaluating tezepelumab for severe asthma in Korean patients is not yet recruiting, sponsor is Asan Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: Asan Medical Center | Conditions: Asthma | Status: NOT_YET_RECRUITING